AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol (October 15, 2008). doi:10.1152/ajprenal.90297.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/F1836    most recent
90297.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahid, M.
Right arrow Articles by Majid, D. S.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahid, M.
Right arrow Articles by Majid, D. S.A.
Submitted on May 7, 2008
Revised on September 29, 2008
Accepted on October 8, 2008

Tumor Necrosis Factor-alpha induces renal vasoconstriction as well as natriuresis in mice

Mohd Shahid1, Joseph Francis2, and Dewan S.A. Majid3*

1 Tulane University Health Sciences Center
2 LSU-School of Veterinary Medicine
3 Tulane University School of Medicine

* To whom correspondence should be addressed. E-mail: majid{at}tulane.edu.

Tumor necrosis factor-alpha (TNF-{alpha}) has been implicated in the pathogenesis of hypertension and renal injury. However, the direct effects of TNF-{alpha} on renal hemodynamic and excretory function are not yet clearly defined. We examined the renal responses to infusion of TNF-{alpha} (0.33 ng/g/min) in anesthetized mice. Renal blood flow (RBF) and glomerular filtration rate (GFR) were determined by PAH and Inulin clearance. The urine was collected from a cannula inserted into the bladder. Following the 60 min control clearance period, TNF-{alpha} infusion was initiated and 15 min were given for stabilization followed by another 60 min clearance period. TNF-{alpha} alone (n=7) caused decreases in RBF (7.9±0.3 to 6.4±0.3 mL/min/g) and GFR (1.04±0.06 to 0.62±0.08 mL/min/g) as well as increases in absolute (0.8±0.3 to 1.4±0.3 mmol/min/g) and fractional excretion of sodium (0.5±0.2 to1.5±0.4%) without affecting arterial pressure. TNF-{alpha} also increased 8-isoprostane excretion (8.10±1.09 to 11.13±1.34 pg/min/g). Pre-treatment with TNF-{alpha} blocker, etanercept (5 mg/kg, s.c; 24 & 3 hr before TNF-{alpha} infusion; n=6) abolished these responses. However, TNF-{alpha} induced an increase in RBF and caused attenuation of the GFR reduction in mice pre-treated with superoxide (O2-) scavenger, tempol (2µg/gm/min; n=6). Pre-treatment with nitric oxide (NO) synthase inhibitor, L-NAME (0.1µg/gm/min; n=6) resulted in further enhancement in vasoconstriction while natriuresis remained unaffected in response to TNF-{alpha}. These data suggest that TNF-{alpha} induces renal vasoconstriction and hypofiltration via enhancing the activity of O2- and thus, reducing the activity of NO. The natriuretic response to TNF-{alpha} is related to its direct effects on tubular sodium reabsorption.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.